BioSpace News Archive

Drug Development

Acceleron Abandons Charcot-Marie-Tooth Program After Trial Failure

ACE-083 was the company’s lead product candidate for its neuromuscular therapeutic program.

March 10, 2020
·
2 min read
·
Mark Terry
Drug Development

Following Restructuring Announcement, FDA Slaps Partial Hold on Unum’s Phase I Trial

The company disclosed that the U.S. Food and Drug Administration placed a partial clinical hold on its Phase I trial for non-Hodgkin lymphoma due to a safety concern.

March 10, 2020
·
2 min read
·
Alex Keown
Sartorius Launches BIOSTAT STR® Generation 3 with BIOBRAIN - Making Biopharmaceutical Development and Production Faster, Simpler and Safer

Engineered to address the rigorous requirements and complexity of biologics manufacture, Sartorius’ BIOSTAT STR® Generation 3 single-use bioreactor and BIOBRAIN automation platform introduce innovations that will change the field of biopharmaceutical process development and manufacturing.

March 10, 2020
·
4 min read
BioForest

Gates Foundation and Two Other Major Charities Pledge $125 Million to Jumpstart Coronavirus Treatments

The Gates Foundation and the Wellcome Trust are contributing up to $50 million each, with the Mastercard Impact Fund offering up to $25 million for initial projects.

March 10, 2020
·
2 min read
·
Mark Terry
FDA

FDA Approves Boehringer Ingelheim’s Ofev for Wider Use in Lung Disease

The U.S. Food and Drug Administration approved Boehringer Ingelheim’s Ofev (nintedanib) for patients with chronic fibrosing interstitial lung diseases with a progressive phenotype.

March 10, 2020
·
2 min read
·
Mark Terry
Arkin Launches $140 Million Fund Aimed at Novel and Gene Therapies

Arkin Holdings launched a new $140 million fund that aims to invest in 10 to 12 private companies developing different types of therapies for indications with high unmet needs.

March 10, 2020
·
2 min read
·
Alex Keown
Deals

Numab Therapeutics Closes Series B Financing at CHF 22M to Advance Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology

Numab Therapeutics announced the closing of its Series B financing round at a total volume of CHF 22M. New investors in this round included 3SBio/Sunshine Guojian, Mitsubishi UFJ Capital Co., Ltd. and Eisai Co., Ltd. as well as Numab’s board member Dr. Daniel Vasella.

March 10, 2020
·
2 min read
BioCapital

Maryland Booms in the BioCapital Hotbed

As the BioCapital Hotbed continues to grow, the state of Maryland is seeing a boom in life sciences employment as multiple companies build out manufacturing facilities in the state.

March 10, 2020
·
4 min read
·
Alex Keown
Policy

FDA and FTC Issue Warning Letters to Seven Companies Selling Fraudulent COVID-19 ‘Treatments’

The U.S. Food and Drug Administration is putting a halt to the sale of alleged treatments for COVID-19 due to concerns about the safety risks these products could have to the public.

March 10, 2020
·
2 min read
·
Alex Keown
BioMidwest

How Biogen and Other Biopharma Companies Are Responding to COVID-19

Numerous organizations are cancelling or postponing activities that involve large groups of people.

March 10, 2020
·
4 min read
·
Mark Terry